These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37510310)

  • 1. High Expression of
    Wang Y; Zhao Y; Zhang Z; Zhang J; Xu Q; Zhou X; Mao L
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510310
    [No Abstract]   [Full Text] [Related]  

  • 2. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma.
    Mou Y; Zhang L; Liu Z; Song X
    BMC Cancer; 2022 Feb; 22(1):215. PubMed ID: 35227235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y; Tu Z; Lei K; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.
    Chen Z; Wu T; Yan Z; Zhang M
    Front Cell Dev Biol; 2021; 9():652599. PubMed ID: 34249910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity.
    Liu S; Wang Y; Miao C; Xing Q; Wang Z
    Cancer Cell Int; 2021 Mar; 21(1):140. PubMed ID: 33648519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Ferroptosis-Related Gene Prognostic Index to Predict Temozolomide Sensitivity and Immune Checkpoint Inhibitor Response for Glioma.
    Cai Y; Liang X; Zhan Z; Zeng Y; Lin J; Xu A; Xue S; Xu W; Chai P; Mao Y; Song Z; Han L; Xiao J; Song Y; Zhang X
    Front Cell Dev Biol; 2021; 9():812422. PubMed ID: 35174170
    [No Abstract]   [Full Text] [Related]  

  • 8. Remarkable immune and clinical value of novel ferroptosis-related genes in glioma.
    Gao X; Zhao J; Jia L; Zhang Q
    Sci Rep; 2022 Jul; 12(1):12854. PubMed ID: 35896732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis-related NFE2L2 and NOX4 Genes are Potential Risk Prognostic Biomarkers and Correlated with Immunogenic Features in Glioma.
    Lin L; Li X; Zhu S; Long Q; Hu Y; Zhang L; Liu Z; Li B; Li X
    Cell Biochem Biophys; 2023 Mar; 81(1):7-17. PubMed ID: 36627482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF2-ferroptosis related gene is associated with prognosis and EMT in gliomas.
    Tong S; Ye L; Xu Y; Sun Q; Gao L; Cai J; Ye Z; Tian D; Chen Q
    Transl Oncol; 2022 Dec; 26():101544. PubMed ID: 36156371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas.
    Li J; Zhang Y; Qu Z; Ding R; Yin X
    Front Cell Infect Microbiol; 2022; 12():956801. PubMed ID: 35959373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research into the characteristic molecules significantly affecting liver cancer immunotherapy.
    Chen J; Jin H; Zhou H; Hei X; Liu K
    Front Immunol; 2023; 14():1029427. PubMed ID: 36860864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis.
    Xu Z; Chen X; Song L; Yuan F; Yan Y
    Front Immunol; 2022; 13():834595. PubMed ID: 35281049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifaceted bioinformatic analysis of m6A-related ferroptosis and its link with gene signatures and tumour-infiltrating immune cells in gliomas.
    Yang Y; Hao L; Guiyang L; Haozhe P
    J Cell Mol Med; 2024 Sep; 28(17):e70060. PubMed ID: 39248438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of transferrin receptor protein 1 for predicting prognosis and immune infiltration in lower grade glioma.
    Wu H; He H; Huang J; Wang C; Dong Y; Lin R; Cheng Z; Qiu Q; Hong L
    Front Mol Neurosci; 2022; 15():972308. PubMed ID: 36483569
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Ge X; Xu M; Cheng T; Hu N; Sun P; Lu B; Wang Z; Li J
    Front Immunol; 2022; 13():974346. PubMed ID: 36275718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
    Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
    Front Neurol; 2022; 13():977180. PubMed ID: 36353126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma.
    Zhou Q; Zhou J; Fan J
    Front Oncol; 2021; 11():638803. PubMed ID: 34094918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients.
    Xiang Z; Chen X; Lv Q; Peng X
    Front Genet; 2021; 12():697819. PubMed ID: 34408772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.